...
首页> 外文期刊>European urology supplements: official journal of the European Association of Urology >Ureteroscopic Management of Patients with Upper Tract Transitional Cell Carcinoma
【24h】

Ureteroscopic Management of Patients with Upper Tract Transitional Cell Carcinoma

机译:上路移行细胞癌患者的输尿管镜治疗

获取原文
获取原文并翻译 | 示例
           

摘要

Objectives: This paper reviews the indications, technique, and treatment outcomes for the ureteroscopic management of upper tract transitional cell carcinomas (UTTCCs). Methods: The author reports on his experience and reviews of the most recent data published in the literature. Results: The expanding experience with minimally invasive techniques to treat UTTCCs has demonstrated its safety and efficacy in selected patients. Diagnostic accuracy can be enhanced and pathologic confirmation of tumour grade and stage can be regularly obtained. In selected patients with unique, small tumours with low grade and low stage, the results of endoscopic management are encouraging. Patients with a functional solitary kidney, bilateral disease, or renal insufficiency can also be considered for conservative treatment. The patient must be willing to and capable of undergoing vigilant and frequent endoscopies during the follow-up. However, conservative management remains controversial in a patient with low-grade/low-stage disease and a normal contralateral kidney. Conclusions: Ureteroscopic management of UTTCC is feasible and safe using, preferably, laser fulguration.
机译:目的:本文综述了输尿管镜治疗上段移行细胞癌(UTTCC)的适应症,技术和治疗结果。方法:作者报告了他的经验并回顾了文献中发表的最新数据。结果:使用微创技术治疗UTTCC的不断发展的经验表明,它对部分患者的安全性和有效性。可以提高诊断的准确性,并可以定期获得肿瘤分级和分期的病理学确认。在选择的具有低度和低分期的独特,小肿瘤的患者中,内镜治疗的结果令人鼓舞。患有功能性孤立性肾脏,双侧疾病或肾功能不全的患者也可以考虑进行保守治疗。在随访期间,患者必须愿意并且能够进行警惕和频繁的内镜检查。然而,对于低度/低度疾病和对侧肾脏正常的患者,保守治疗仍然存在争议。结论:UTTCC的输尿管镜治疗是可行的并且安全的,最好使用激光引流术。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号